Investigation of the Subcellular Distribution of the Bcl-2 Oncoprotein: Residence in the Nuclear Envelope, Endoplasmic Reticulum, and Outer Mitochondrial Membranes
Overview
Affiliations
A multidisciplinary approach was taken to investigate the intracellular locations of the 26-kDa integral membrane protein encoded by the bcl-2 gene. Subcellular fractionation analysis of a t(14;18)-containing lymphoma cell line revealed the presence of Bcl-2 protein in nuclear, heavy-membrane, and light-membrane fractions but not in cytosol. Sedimentation of heavy-membrane fractions in Nycodenz and Percoll continuous gradients demonstrated comigration of p26-Bcl-2 with mitochondrial but not other organelle-associated proteins. Fractionation of light-membrane fractions using discontinuous sucrose-gradients revealed association of Bcl-2 protein primarily with lighter-density microsomes (smooth endoplasmic reticulum) as opposed to heavy-density microsomes (rough endoplasmic reticulum). Immune microscopy studies using laser-scanning microscopy, pre- and postembedding electron microscopic methods, and six different anti-Bcl-2 antibodies demonstrated Bcl-2 immunoreactivity in the nuclear envelope and outer mitochondrial membrane in a patchy distribution. Furthermore, anti-Bcl-2 antibody immunoreactivity generally appeared to directly overlie the nuclear envelope in high magnification electron microscopic studies, reminiscent of nuclear pore complexes. Addition of in vitro translated p26-Bcl-2 to isolated translocation-competent mitochondria revealed transmembrane domain-dependent association of Bcl-2 protein with mitochondria but provided no evidence for import into a protease-resistant compartment, consistent with immunomicroscopic localization to the outer mitochondrial membrane. Taken together, the findings demonstrate that p26-Bcl-2 resides primarily in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membrane in a nonuniform distribution suggestive of participation in protein complexes perhaps involved in some aspect of transport.
Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function.
Perez-Serna A, Guzman-Llorens D, Dos Santos R, Marroqui L Biomedicines. 2025; 13(1).
PMID: 39857806 PMC: 11760435. DOI: 10.3390/biomedicines13010223.
Moustapha A, Andreu P, Gonzalvez F, Fradin D, Tissier J, Diolez P J Biol Methods. 2025; 11(4):e99010040.
PMID: 39839094 PMC: 11744068. DOI: 10.14440/jbm.2024.0055.
Bik promotes proteasomal degradation to control low-grade inflammation.
Mebratu Y, Jones J, Liu C, Negasi Z, Rahman M, Rojas-Quintero J J Clin Invest. 2023; 134(4.
PMID: 38113109 PMC: 10866658. DOI: 10.1172/JCI170594.
Hedayat M, Khezri M, Jafari R, Malekinejad H, Zolbanin N Med Oncol. 2023; 40(9):263.
PMID: 37548777 DOI: 10.1007/s12032-023-02119-1.
Mitochondria dysfunction and bipolar disorder: From pathology to therapy.
Lam X, Xu B, Yeo P, Cheah P, Ling K IBRO Neurosci Rep. 2023; 14:407-418.
PMID: 37388495 PMC: 10300489. DOI: 10.1016/j.ibneur.2023.04.002.